All current DZIF news can be found here.

idt Abfüllanlage
© Hartmut Bösener/IDT Biologika

Study with optimized vector vaccine MVA-SARS-2-S resumed

The clinical review of the MVA-SARS-2-S vector vaccine against COVID-19 will continue with a new version. The DZIF (German Center for Infection Research) scientists temporarily suspended the study

UNITE4TB marks a new era in tuberculosis treatment development

To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions for TB patients worldwide, a new consortium of 30 partners from 13 countries has

Stefan Niemann
© FZ Borstel/Pukall

Stefan Niemann receives the Gardner Middlebrook Award 2021

The molecular biologist Prof. Stefan Niemann from the Research Center Borstel, Leibniz Lung Center was honored with the Gardner Middlebrook Lifetime Achievement Award. The award was presented online

Autophagie und SARS
© UKB/Daniel Heinz

A tapeworm drug against SARS-CoV-2?

Researchers from the German Center for Infection Research (DZIF) at Charité – Universitätsmedizin Berlin and the University of Bonn have examined the way in which SARS-CoV-2 reprograms the metabolism

Team um Jan Rybniker
© Uniklinik Köln, Foto: Christoph Wanko

Long-lasting and profound reprogramming of immune cells after COVID-19

SARS-CoV-2 infection causes severe inflammation of the lungs and other vital organs. Why some infected individuals respond with an exaggerated immune response to the virus remains not well understood

Computer model
© Dräger/Renz/Widerspick

SARS-CoV-2: A computer model to visualise possible attack points of viruses and virus mutants

There is still an urgent need for drugs against the new coronavirus. This urgency increases further with the emergence of new virus mutations that could push vaccines to their limits. For more than a

Test tubes
© Charité/ Victor Corman

SARS-CoV-2: Estimating infectiousness

What started as the preliminary analysis of routine laboratory data has since evolved into the largest-ever study of viral load levels in patients with SARS-CoV-2. A team of researchers from the

Staphylococcus aureus

From harmless skin bacteria to dreaded pathogens

An international research team, led by scientists from Tübingen and the German Center for Infection Research (DZIF) discovers additional component in staphylococcal cell wall that turns the bacterium

© Universität Tübingen / Paul Mehnert

Tübingen study raises hope for effective malaria vaccine

At the University Hospital of Tübingen, a clinical trial led by Prof. Dr. Peter Kremsner, Director of the Institute of Tropical Medicine, Travel Medicine and Human Parasitology and Dr. Rolf Fendel

Kamele in Dubai

MERS coronavirus: Vaccine development is going into the next round

In addition to the SARS coronavirus-2 that is currently prevalent worldwide, scientists continue to keep an eye on the related MERS coronavirus, as it, too, could potentially become a supra-regional